001     143640
005     20240229112601.0
024 7 _ |a 10.1007/s00401-019-02021-z
|2 doi
024 7 _ |a pmid:31062076
|2 pmid
024 7 _ |a 0001-6322
|2 ISSN
024 7 _ |a 1432-0533
|2 ISSN
024 7 _ |a altmetric:60082153
|2 altmetric
037 _ _ |a DKFZ-2019-01217
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Wirthschaft, Peter
|0 P:(DE-He78)7f9dda5a1b9a9ffc384598e80ade05f9
|b 0
|e First author
|u dkfz
245 _ _ |a RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas.
260 _ _ |a Heidelberg
|c 2019
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1686741925_24958
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Glioblastomas strongly invade the brain by infiltrating into the white matter along myelinated nerve fiber tracts even though the myelin protein Nogo-A prevents cell migration by activating inhibitory RhoA signaling. The mechanisms behind this long-known phenomenon remained elusive so far, precluding a targeted therapeutic intervention. This study demonstrates that the prevalent activation of AKT in gliomas increases the ER protein-folding capacity and enables tumor cells to utilize a side effect of RhoA activation: the perturbation of the IRE1α-mediated decay of SPARC mRNA. Once translation is initiated, glioblastoma cells rapidly secrete SPARC to block Nogo-A from inhibiting migration via RhoA. By advanced ultramicroscopy for studying single-cell invasion in whole, undissected mouse brains, we show that gliomas require SPARC for invading into white matter structures. SPARC depletion reduces tumor dissemination that significantly prolongs survival and improves response to cytostatic therapy. Our finding of a novel RhoA-IRE1 axis provides a druggable target for interfering with SPARC production and underscores its therapeutic value.
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Bode, Julia
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Soni, Himanshu
|0 P:(DE-He78)34d5c41508d3317e721bfb593ef5948d
|b 2
|u dkfz
700 1 _ |a Dietrich, Fabio
|0 P:(DE-He78)268bacdaa8869513e9bbb14f2b838ada
|b 3
|u dkfz
700 1 _ |a Krüwel, Thomas
|0 P:(DE-He78)d9984bb7c7ce85fffd8c63899fb1d7fa
|b 4
|u dkfz
700 1 _ |a Fischer, Bernd
|0 P:(DE-He78)5e8c9e37b2ec5e928b6170cf9ecf9770
|b 5
|u dkfz
700 1 _ |a Knobbe-Thomsen, Christiane B
|b 6
700 1 _ |a Rossetti, Giulia
|b 7
700 1 _ |a Hentschel, Andreas
|b 8
700 1 _ |a Mack, Norman
|0 P:(DE-He78)e73a0a4fab40344d89d693cbe1df3109
|b 9
|u dkfz
700 1 _ |a Schönig, Kai
|b 10
700 1 _ |a Breckwoldt, Michael O
|0 P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303
|b 11
|u dkfz
700 1 _ |a Schmandke, André
|b 12
700 1 _ |a Pusch, Stefan
|0 P:(DE-He78)f2efee17b6ca2f790176a2c036912536
|b 13
|u dkfz
700 1 _ |a Medenbach, Jan
|b 14
700 1 _ |a Bendszus, Martin
|b 15
700 1 _ |a Schwab, Martin E
|b 16
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 17
|u dkfz
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 18
|u dkfz
700 1 _ |a Herold-Mende, Christel
|b 19
700 1 _ |a Reifenberger, Guido
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Ahrends, Robert
|b 21
700 1 _ |a Tews, Björn
|0 P:(DE-He78)a33ae52a1d80b847405db3ab83b9e90d
|b 22
|e Last author
|u dkfz
773 _ _ |a 10.1007/s00401-019-02021-z
|0 PERI:(DE-600)1458410-4
|n 2
|p 275-293
|t Acta neuropathologica
|v 138
|y 2019
|x 1432-0533
909 C O |p VDB
|o oai:inrepo02.dkfz.de:143640
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)7f9dda5a1b9a9ffc384598e80ade05f9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)34d5c41508d3317e721bfb593ef5948d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)268bacdaa8869513e9bbb14f2b838ada
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)d9984bb7c7ce85fffd8c63899fb1d7fa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)5e8c9e37b2ec5e928b6170cf9ecf9770
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)e73a0a4fab40344d89d693cbe1df3109
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)f2efee17b6ca2f790176a2c036912536
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)a33ae52a1d80b847405db3ab83b9e90d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Addenda
|x 0
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA NEUROPATHOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b ACTA NEUROPATHOL : 2017
920 1 _ |0 I:(DE-He78)V077-20160331
|k V077
|l AG Molekulare Mechanismen der Tumorzell-Invasion
|x 0
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 1
920 1 _ |0 I:(DE-He78)D170-20160331
|k D170
|l KKE Neuroimmunologie und Hirntumorimmunologie
|x 2
920 1 _ |0 I:(DE-He78)B300-20160331
|k B300
|l KKE Neuropathologie
|x 3
920 1 _ |0 I:(DE-He78)L401-20160331
|k L401
|l DKTK Essen
|x 4
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)V077-20160331
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)D170-20160331
980 _ _ |a I:(DE-He78)B300-20160331
980 _ _ |a I:(DE-He78)L401-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21